Senti Biosciences Holdings (SNTI) Receivables - Net (2022 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Receivables - Net of $500000.0 for Q4 2025, down 28.57% year-over-year from $700000.0 in Q4 2024, and down 68.69% quarter-over-quarter from $1.6 million in Q3 2025.
Senti Biosciences Holdings (SNTI) Receivables - Net (2022 - 2025) Analysis & Trends
Senti Biosciences Holdings' Receivables - Net history runs 4 years deep, the most recent figure standing at $500000.0 for Q4 2025.
- In Q4 2025, Receivables - Net fell 28.57% year-over-year to $500000.0; the TTM figure through Dec 2025 stood at $500000.0 (down 28.57% YoY), while the FY2025 annual figure was $500000.0, down 28.57% from the prior year.
- Receivables - Net for Q4 2025 stood at $500000.0, down from $1.6 million in the prior quarter.
- The five-year high for Receivables - Net was $17.8 million in Q1 2024, with the low at $500000.0 in Q4 2025.
- The 4-year median for Receivables - Net is $900000.0 (2024), against an average of $3.5 million.
- Peak annual rise in Receivables - Net reached 2156.26% in 2024, while the deepest fall reached 96.02% in 2024.
- Senti Biosciences Holdings' Receivables - Net stood at $846000.0 in 2022, then surged by 1979.43% to $17.6 million in 2023, then plunged by 96.02% to $700000.0 in 2024, then retreated by 28.57% to $500000.0 in 2025.
- Business Quant data shows SNTI's Receivables - Net at $500000.0 in Q4 2025, $1.6 million in Q3 2025, and $3.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Senti Biosciences Holdings | 12.40 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 17.85 Mn |
| Mar 31, 2024 | 17.85 Mn |
| Dec 31, 2023 | 17.59 Mn |
| Dec 31, 2023 | 17.59 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |